Latest News

ATFX Secures License from Cambodia's Securities and Exchange Regulator (SERC)

HONG KONG, June 2, 2025 /PRNewswire/ -- ATFX , a globally recognized broker, is thrilled to announce it has secured its license from the Securities and Exchange Regulator of Cambodia (SERC) under License Number 040(date of issue: 18 March 2025), enabling the company to o...

2025-06-02 11:00 3537

International Healthcare Week 2025 - Innovate, Collaborate, And Elevate Healthcare In ASEAN And Beyond

KUALA LUMPUR, Malaysia, June 2, 2025 /PRNewswire/ -- International Healthcare Week (IHW) 2025, Southeast Asia's premier healthcare event, will be held from July 16 to 18 at the Malaysia International Trade and Exhibition Centre (MITEC), Kuala Lumpur. Organised by Informa Markets, IHW 2025 is set ...

2025-06-02 10:59 4768

J INTS BIO to Present Global Clinical Results from JIN-A02, a Fourth-Generation EGFR-TKI, at ASCO 2025

Significant anti-tumor responses and reduction of brain metastases observed SEOUL, South Korea, June 1, 2025 /PRNewswire/ -- J INTS BIO, a company specializing in the development of therapeutics for cancer and rare diseases, officially announced interim results from the global Phase 1/2 clini...

2025-06-02 10:22 3274

Medidata Debuts Protocol Optimization at ASCO, Leveraging AI to Transform the Study Experience

New solution improves protocol design, reduces patient- and site-burden, accelerates recruitment, and delivers increased efficiencies for clinical trials  SINGAPORE, June 2, 2025 /PRNewswire/ -- Medidata , a Dassault Systèmes brand and leading provider of clinical...

2025-06-02 09:00 3219

ASP Isotopes and Isotopia Announce Supply Agreement for Gadolinium-160 to Accelerate Terbium-161 Production for Advanced Cancer Therapies

PETACH TIKVA, Israel, June 2, 2025 /PRNewswire/ -- ASP Isotopes Inc. (NASDAQ: ASPI) and Isotopia Molecular Imaging Ltd. have entered into a strategic agreement to secure the supply of Gadolinium-160 (Gd-160), a critical precursor isotope for producing Terbium-161 (Tb-161), an emerging medical iso...

2025-06-02 09:00 3596

EnGenius Showcases Smarter AI and Cloud Networking Solutions at Interop Tokyo 2025

Cloud-Managed Wi-Fi 7 and AI Surveillance Solutions That Drive Innovation in Education, Hospitality, and Healthcare TOKYO, June 2, 2025 /PRNewswire/ -- EnGenius Networks Japan, the Japanese subsidiary of global cloud networking leader EnGenius Technologies, will exhibit its latest cloud-managed ...

2025-06-02 09:00 4614

TuniTuni Opens New Storytelling Kids' Gym in Shek Mun, Hong Kong

HONG KONG, June 2, 2025 /PRNewswire/ -- TuniTuni, the beloved Korean kids' gym brand, is thrilled to announce the opening of its second Hong Kong center in Shek Mun on 1st June 2025. Located at Unit N, P. 19/F Kings Wing Plaza 2, No 1 On Kwan Street, Shatin, this new facility follows the phenomen...

2025-06-02 08:53 5055

Unlocking Trillions: How Data Fuels China- Thailand Business Boom

SHENZHEN, China, June 2, 2025 /PRNewswire/ -- This is a news report from Shenzhen Media Group: "When there's a big volume of products from China, it also helps the Thai economy because people can buy things cheaper than produced in Thailand." Recently, Thai Foreign Minister Maris Sangiampongsa r...

2025-06-02 08:30 4437

Dilon Technologies Partners with Australian Allografts as Exclusive Distributor for Navigator 2.0™ Gamma Localization System in Australia

NEWPORT NEWS, Va., June 2, 2025 /PRNewswire/ -- Dilon Technologies is pleased to announce the partnership ofAustralian Allografts as the exclusive distributor of theNavigator 2.0™ Lymphatic Mapping System in Australia, effective immediately. This strategic collaboration reflects Dilon Technologi...

2025-06-02 08:22 2586

Peacock 1953 Aircraft Hand Watch: Heritage Meets Horological Innovation in a Tribute to China's Watchmaking Pioneers

SHENZHEN, China, June 1, 2025 /PRNewswire/ -- Peacock  Watch today launches thePeacock Perfection Classic 1953 "Aircraft Hand" , a limited-e...

2025-06-02 08:19 3060

CARsgen Presents Research Results on Satri-cel in The Lancet and at the 2025 ASCO Annual Meeting

SHANGHAI, June 1, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces that the results of the pivotal Phase II clinical trial in China (CT041-ST-01, NCT04581473) investigating satricabtagene au...

2025-06-02 08:15 2607

2025 ASCO Oral Presentation: Innovent Biologics Announces Updated Date of IBI363 (First-in-class PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) from Phase 1 Clinical Studies in Advanced Colorectal Cancer

SAN FRANCISCO, and SUZHOU, China, June 1, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic...

2025-06-02 08:00 4685

Hyundai Capital Australia Launches Kia Finance, Expanding its Finance Offerings to All Hyundai Motor Group Vehicles

SEOUL, South Korea, June 2, 2025 /PRNewswire/ -- Hyundai Capital Services announced today that its Australian subsidiary Hyundai Capital Australia Pty. Ltd. ("HCAU" or the "Company") launched Kia Finance and has commenced offering finance solutions for Kia customers in Australia. Last year, HC...

2025-06-02 07:00 4561

BreastScreen Australia Density Reporting Rule is a Critical Step for Women says Volpara Health, the Leader in AI-assisted Breast Density Measurement

Volpara software is used to assess the breast density of more than 1 million Australian women annually WELLINGTON, New Zealand, June 2, 2025 /PRNewswire/ -- Volpara Health, a Lunit a company and global leader in software for the early detection of breast cancer, today applauded the significant ...

2025-06-02 06:00 3112

Mérieux NutriSciences and AsureQuality Announce the Official Launch of Mérieux NutriSciences AQ (MNAQ) Joint Venture

CHICAGO and AUCKLAND, New Zealand, June 2, 2025 /PRNewswire/ -- Mérieux NutriSciences, a global leader in food safety, quality, and sustainability, and AsureQuality,New Zealand's premier food assurance provider, are pleased to announce the official launch of their joint venture,Mérieux NutriScien...

2025-06-02 05:00 4032

Mérieux NutriSciences and AsureQuality Announce the Official Launch of Mérieux NutriSciences AQ (MNAQ) Joint Venture

CHICAGO and AUCKLAND, New Zealand, June 2, 2025 /PRNewswire/ -- Mérieux NutriSciences, a global leader in food safety, quality, and sustainability, and AsureQuality, New Zealand's premier food assurance provider, are pleased to announce the official launch of their joint venture,Mérieux NutriScie...

2025-06-02 05:00 2867

Xinhua Silk Road: 21st Shanghai Suzhou Creek Dragon Boat Invitational Tournament concludes with record participation

BEIJING, June 1, 2025 /PRNewswire/ -- The 21st Shanghai Suzhou Creek Dragon Boat Invitational Tournament wrapped up on May 25 in Putuo District of Shanghai, setting a new record for participation over the past decade. A total of 58 teams from various countries and regions took part in the vibrant...

2025-06-01 22:18 4901

China Liberal Education Holdings Limited Announces Suspension of Nasdaq Trading

BEIJING, June 1, 2025 /PRNewswire/ -- China Liberal Education Holdings Limited ("China Liberal" or the "Company") (Nasdaq: CLEU), aChina-based company that provides technological consulting services for smart campus solutions and other educational services, today announced that onMay 30, 2025, th...

2025-06-01 20:00 4745

Blokees made its debut at CCXP México 2025, Officially Enters México Market

SHANGHAI, June 1, 2025 /PRNewswire/ -- On May 30, 2025, the most influential pop culture exhibition in Latin America, CCXP Mexico 2025, grandly opened in Mexico. Chinese building block character toy brand Blokees brought multiple IP series products to the exhibition for the first time.The officia...

2025-06-01 18:56 4406

InxMed Announces Promising Phase Ib/II Clinical Data for Ifebemtinib + KRAS G12C inhibitor in KRAS G12C-Mutant Solid Tumors at ASCO 2025

NANJING, China, June 1, 2025 /PRNewswire/ -- InxMed Co., Ltd, a clinical-stage biotechnological company, pioneering therapies to transform cancer treatment, released latest clinical data from a Phase Ib/II clinical trial (NCT06166836; NCT05379946) to evaluate the efficacy and safety of ifebemtini...

2025-06-01 15:00 4032